BioVie

(NASDAQ) BIVI

Current Price$1.54

Market Cap$12.52M

Since IPO (2014)-100%

5 Year-100%

1 Year-86%

1 Month+7%

BioVie Financials at a Glance

Market Cap

$12.52M

Revenue (TTM)

$0.00

Net Income (TTM)

$17.43M

EPS (TTM)

$-5.08

P/E Ratio

-0.33

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Price

$1.54

Volume

2,031

Open

$1.69

Price

$1.54

Volume

2,031

Open

$1.69

Previous Close

$1.54

Daily Range

$1.54 - $1.69

52-Week Range

$1.06 - $12.40

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Price

$1.54

Volume

2,031

Open

$1.69

Previous Close

$1.54

Daily Range

$1.54 - $1.69

52-Week Range

$1.06 - $12.40

BIVI News

Sick Old Woman in a Wheelchair is Receiving a Help From a Young Nurse in Home Visit

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioVie

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Cuong Viet Do, MBA

Website

www.bioviepharma.com

Headquarters

Carson City, NV 89703, US

BIVI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-81%

Return on Capital

-93%

Return on Assets

-77%

Earnings Yield

-3.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.52M

Shares Outstanding

7.54M

Volume

2.03K

Avg. Volume

83.69K

Financials (TTM)

Gross Profit

$229.38K

Operating Income

$18.07M

EBITDA

$16.98M

Operating Cash Flow

$19.03M

Capital Expenditure

$0.00

Free Cash Flow

$19.03M

Cash & ST Invst.

$17.54M

Total Debt

$349.89K

BioVie Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$57.34K

N/A

Gross Margin

0.00%

N/A

Market Cap

$12.52M

N/A

Market Cap/Employee

$894.45K

N/A

Employees

N/A

Net Income

$6.07M

+14.7%

EBITDA

$6.01M

+17.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$20.23M

-15.8%

Accounts Receivable

$195.48K

N/A

Inventory

$0.00

N/A

Long Term Debt

$232.52K

-26.2%

Short Term Debt

$82.40K

+22.8%

Return on Assets

-77.48%

N/A

Return on Invested Capital

-93.34%

N/A

Free Cash Flow

$4.44M

+48.3%

Operating Cash Flow

$4.44M

+48.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ARTLArtelo Biosciences, Inc.

ARTLArtelo Biosciences, Inc.$2.68-3.60%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$2.16+1.41%

GLMDGalmed Pharmaceuticals Ltd.

GLMDGalmed Pharmaceuticals Ltd.$0.63-0.22%

KZIAKazia Therapeutics Limited

KZIAKazia Therapeutics Limited$13.41-3.11%

INMInMed Pharmaceuticals Inc.

INMInMed Pharmaceuticals Inc.$0.70-4.13%

LIPOLipella Pharmaceuticals Inc.

LIPOLipella Pharmaceuticals Inc.$0.03-15.87%

CEROCERo Therapeutics Holdings, Inc.

CEROCERo Therapeutics Holdings, Inc.$0.03-10.68%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

INTCIntel

INTCIntel$109.62-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

IRENIren

IRENIren$56.85-0.07%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

Questions About BIVI

What is the current price of BioVie?

BioVie is trading at $1.54 per share.

What is the 52-week range for BioVie?

Over the past 52 weeks, BioVie has traded between $1.06 and $12.40.

How much debt does BioVie have?

As of the most recent reporting period, BioVie reported total debt of $314,915.

How much cash does BioVie have on hand?

BioVie reported $20.54M in cash and cash equivalents in its most recent financial results.

What is BioVie’s dividend yield?

BioVie does not currently have a dividend yield.

BioVie

BioVie Financials at a Glance

BIVI News

Why Shares of BioVie Jumped This Week

Why Shares of BioVie Jumped 51.7% in February

Why Shares of BioVie Rose 15.3% in December

Why BioVie Stock Is Soaring Today

Why BioVie's Shares Tumbled Tuesday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioVie

BIVI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioVie Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIVI

What is the current price of BioVie?

What is the 52-week range for BioVie?

How much debt does BioVie have?

How much cash does BioVie have on hand?

What is BioVie’s dividend yield?

Premium Investing Services